Search Results - "Hoch, Lucile"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Targeting of Smoothened for therapeutic gain by Ruat, Martial, Hoch, Lucile, Faure, Hélène, Rognan, Didier

    “…Highlights • Smo antagonists have potential for cancer therapy. • Positive modulators of Smo may also be therapeutics. • Models of canonical and noncanonical…”
    Get full text
    Journal Article
  2. 2

    Generation of three induced pluripotent stem cell lines from patients with glycogen storage disease type III by Rossiaud, Lucille, Pellier, Emilie, Benabides, Manon, Nissan, Xavier, Ronzitti, Giuseppe, Hoch, Lucile

    Published in Stem cell research (01-10-2023)
    “…Glycogen storage disease type III (GSDIII) is an autosomal recessive disorder characterized by a deficiency of glycogen debranching enzyme (GDE) leading to…”
    Get full text
    Journal Article
  3. 3

    Identification of thiostrepton as a pharmacological approach to rescue misfolded alpha-sarcoglycan mutant proteins from degradation by Hoch, Lucile, Henriques, Sara F., Bruge, Celine, Marsolier, Justine, Benabides, Manon, Bourg, Nathalie, Tournois, Johana, Mahé, Gurvan, Morizur, Lise, Jarrige, Margot, Bigot, Anne, Richard, Isabelle, Nissan, Xavier

    Published in Scientific reports (06-05-2019)
    “…Limb-girdle muscular dystrophy type 2D (LGMD2D) is characterized by a progressive proximal muscle weakness. LGMD2D is caused by mutations in the gene encoding…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies by Bruge, Celine, Geoffroy, Marine, Benabides, Manon, Pellier, Emilie, Gicquel, Evelyne, Dhiab, Jamila, Hoch, Lucile, Richard, Isabelle, Nissan, Xavier

    Published in Biomedicines (16-06-2022)
    “…Limb girdle muscular dystrophies (LGMD), caused by mutations in 29 different genes, are the fourth most prevalent group of genetic muscle diseases. Although…”
    Get full text
    Journal Article
  6. 6
  7. 7

    MRT‐92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor by Hoch, Lucile, Faure, Helene, Roudaut, Hermine, Schoenfelder, Angele, Mann, Andre, Girard, Nicolas, Bihannic, Laure, Ayrault, Olivier, Petricci, Elena, Taddei, Maurizio, Rognan, Didier, Ruat, Martial

    Published in The FASEB journal (01-05-2015)
    “…ABSTRACT The Smoothened (Smo) receptor, a member of class F G protein‐coupled receptors, is the main transducer of the Hedgehog (Hh) signaling pathway…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Design, synthesis and biological characterization of a new class of osteogenic (1H)-quinolone derivatives by Manetti, Fabrizio, Petricci, Elena, Gabrielli, Annalisa, Mann, Andrè, Faure, Hélène, Gorojankina, Tatiana, Brasseur, Laurent, Hoch, Lucile, Ruat, Martial, Taddei, Maurizio

    Published in European journal of medicinal chemistry (04-10-2016)
    “…Smoothened (Smo) is the signal transducer of the Hedgehog (Hh) pathway and its stimulation is considered a potential powerful tool in regenerative medicine to…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Structure of the Smoothened receptor by Ruat, Martial, Hoch, Lucile, Faure, Hélène, Rognan, Didier

    Published in M.S. Médecine sciences (01-10-2013)
    “…The Smoothened (Smo) receptor is a major component involved in signal transduction of the Hedgehog (Hh) morphogens both during embryogenesis and in the adult…”
    Get more information
    Journal Article